Search - tctmd.com

Displaying 81 - 100 of 1457

Sort: Relevancy | Date

Presentation TCT 2016

Hemodynamics of Aortic Stenosis: You CAN Do This

Presenter: Thomas H. Maloney, Jeff Davis

October 29, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR in Left Main Disease

Presenter: William F. Fearon

October 28, 2016

News Daily News

FDA Approves 34-mm TAVR Valve for Patients With Larger Anatomy

L.A. McKeown

October 27, 2016

News Daily News

孕妇主动脉瓣狭窄患者基本都能存活，但遗留许多并发症

October 11, 2016

News Daily News

Las Mujeres Embarazadas con Estenosis Aórtica Casi Siempre Sobreviven Pero con Complicaciones

October 11, 2016

News Daily News

At 3 Years Post-TAVR, Valve Performance Holds Steady and Most Mortality Is Noncardiac: FRANCE 2 Registry

Caitlin E. Cox

October 04, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2016

Shelley Wood

September 30, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2016

Shelley Wood

September 30, 2016

News Daily News

Post-TAVR Cognition Improves in Some Patients and Declines in Others, With Few Signposts to Guide the Way

Shelley Wood

September 29, 2016

News Daily News

New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk

Todd Neale

September 29, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Conference News VIVA 2016

Carotid Stent Fractures Pose Very Little Threat to Patients, Study Finds

L.A. McKeown

September 21, 2016

News Conference News VIVA 2016

IVUS Improves Management of Iliofemoral Venous Stenting

L.A. McKeown

September 20, 2016

News Conference News PCR London Valves 2016

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Shelley Wood

September 20, 2016

News Daily News

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Michael O'Riordan

September 20, 2016

News Conference News PCR London Valves 2016

Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies

Shelley Wood

September 19, 2016

News Industry News

Edwards Sapien 3 Transcatheter Heart Valve Receives Expanded Indication In Europe

September 19, 2016

News Industry News

Boston Scientific Receives CE Mark For LOTUS Edge™ Valve System

September 19, 2016

News Daily News

Elderly Asymptomatic Patients With Severe AS Are Often Treated Too Late

L.A. McKeown

September 16, 2016

News Daily News

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Shelley Wood

September 13, 2016

Advertisement

Hemodynamics of Aortic Stenosis: You CAN Do This

FFR in Left Main Disease

FDA Approves 34-mm TAVR Valve for Patients With Larger Anatomy

孕妇主动脉瓣狭窄患者基本都能存活，但遗留许多并发症

Las Mujeres Embarazadas con Estenosis Aórtica Casi Siempre Sobreviven Pero con Complicaciones

At 3 Years Post-TAVR, Valve Performance Holds Steady and Most Mortality Is Noncardiac: FRANCE 2 Registry

TCTMD’s Top 10 Most Popular Stories for September 2016

TCTMD’s Top 10 Most Popular Stories for September 2016

Post-TAVR Cognition Improves in Some Patients and Declines in Others, With Few Signposts to Guide the Way

New ‘Rapid Recommendations’ Tackle TAVR in Patients at Low-to-Intermediate Risk

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

Carotid Stent Fractures Pose Very Little Threat to Patients, Study Finds

IVUS Improves Management of Iliofemoral Venous Stenting

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies

Edwards Sapien 3 Transcatheter Heart Valve Receives Expanded Indication In Europe

Boston Scientific Receives CE Mark For LOTUS Edge™ Valve System

Elderly Asymptomatic Patients With Severe AS Are Often Treated Too Late

Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content